Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 267

ANZ-IOOF deal mired by conflicts of interest

The A$1 billion sale of OnePath by ANZ is at risk of being stranded in a minefield of internal and external conflicts, caught between doing the right thing by members of the OnePath fund versus obtaining the best deal for shareholders of ANZ, as well as looking after the advisers that will support the fund in future.

And now there is another spanner in the works, one which ANZ’s witnesses at the Royal Commission in Melbourne yesterday were careful not to specify: the reputational risk, in that IOOF may not be the best cultural fit for OnePath after all.

ANZ is now being forced to tread warily, as Victoria Weekes, chair of OnePath Custodians, expressed so diplomatically:

“For OnePath Custodians to provide approval, and at this stage it’s just talking about in-principle approval, it will be conditional upon various matters, including being satisfied that it’s in members’ best interests for things to proceed.”

Michael Hodge, Counsel Assisting the Commissioner, questioned Weekes on some aspects of the decision by ANZ to sell its Wealth business to IOOF.

On the face of it, there are an increasingly complex number of issues emerging, not the least of which being that the sale to IOOF is beginning to look like not being in the best interests of OnePath’s members.

And even so, if the sale is done in a way that minimises capital gains exposure, it will end the payment of trailing commissions to the advisors associated with OnePath under current grandfathering arrangements that stretch back before the introduction of FOFA rules.

This raises obvious questions as to why it is in the OnePath members’ best interests to keep paying commissions to advisers when these could be stopped. But if that happens, the attractiveness of OnePath to potential buyers drops – creating a conflict around what is the best deal for ANZ’s shareholders.

The structure presently consists of a trustee, OnePath Custodians, which is the trustee of two super funds. One of those funds is OnePath Master Fund and the other is the Retirement Portfolio Service.

The Retirement Portfolio Service effectively functions like a superannuation wrap platform, allowing investments into products of a fund member’s choice. In contrast, the OnePath Master Fund contains a variety of different products, including a MySuper product and two Smart Choice Super products – one for retail investors, and another for employers.

The OnePath Master Fund deals with a related party insurer, OnePath Life, and ANZ is also selling this insurance business – although to Zurich.

One consequence of the sale to Zurich is that the OnePath Master Fund will need to unwind its investments through the life insurance policies. The extraction of the investment component parts and superannuation parts from the life insurance, or from the life insurance company, has been proving awkward.

“The preferred method for the trustee of de-linking the OnePath Master Fund from the insurance policy investments is by successor fund transfer of the OnePath Master Fund into the Retirement Portfolio Service,” Weekes said.

One of the main advantages of this method is that it has a capital gains benefit, so if you combine the redemption of those investment linked life policies with a successor fund transfer, then there’s no impact on members of the fund.

Once that successor fund transfer happens, assuming that it does, there will only be one super fund operated by OnePath Custodians, the Retirement Portfolio Service.

And OnePath Custodians will, as part of the IOOF transaction, be sold to IOOF, meeting one of the preconditions.

What’s adding further intrigue to the deal is if the successor fund transfer disturbs Future of Financial Advice grandfathering of commission arrangements – or rather the risk that will flow if grandfathering were not maintained, that was a problem. “Support from the adviser network is critical for the IOOF sale,” Weekes said.

Weekes confirmed that the present status is that OnePath Life pays commissions to advisers, and “the current working assumption is that commissions will continue to be grandfathered.”

Hodge asked: “Has the trustee considered previously why it’s in the best interests of members to continue paying commissions?"

Weekes: “No, not – not in that specific manner, no.”

And then the question of how to deal with IOOF, given their performance in this round of the round commission inquiry.

In response to Hodge’s question as to why the board [of OnePath] is yet to have a presentation from IOOF, Weekes launched into a long explanation that could be summarised as:

“It is a complex process and we need to be clear about what input we want from IOOF and how IOOF will treat OnePath and its members. … to satisfy ourselves as part of a broader package that both the [successor fund transfer] and the transaction will be in members’ best interests.”

 

Bernard Kellerman is Deputy Editor of Banking Day. This article was originally published in Banking Day.


 

Leave a Comment:

RELATED ARTICLES

Conflicted selling fees are back, and it’s game on

Four things advisers can do to manage conflicts

The saga of FoFA (so far) - a reprise from 2014

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.